Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Jan 30, 2021
Product Development
ALS looks up as clinical pipeline explodes
Three late-stage readouts this year and multiple mechanisms in the clinic could lift the lid on ALS treatments
Read More
BioCentury
|
Apr 20, 2018
Clinical News
CHMP rebuffs AB Science’s masitinib in ALS
Read More
BioCentury
|
Apr 19, 2018
Company News
CHMP rebuffs AB Science’s masitinib in ALS
Read More
BioCentury
|
Sep 22, 2017
Clinical News
CHMP issues second recommendation against AB Science's masitinib
Read More
BioCentury
|
Sep 15, 2017
Company News
CHMP issues negative opinions
Read More
BioCentury
|
May 26, 2017
Clinical News
AB Science reports masitinib data in Phase II/III ALS trial
Read More
BioCentury
|
May 19, 2017
Clinical News
AB Science reveals masitinib data in ALS trial
Read More
BioCentury
|
May 19, 2017
Clinical News
CHMP issues negative opinion for AB Science's masitinib after French trials halted
Read More
BioCentury
|
May 12, 2017
Company News
Regulators halt AB Science's French trials of masitinib
Read More
BioCentury
|
May 5, 2017
Clinical News
Ph III trial of masitinib in MS passes IDMC test and completes enrollment
Read More
Items per page:
10
1 - 10 of 63